compound semaglutide ending FDA ends shortage, closing the door on compounded Wegovy, Ozempic FDA Crackdown on Compounded GLP-1

Kozawa J, Inoue K, Iwamoto R, Kurashiki Y, Okauchi Y, Kashine S, Kitamura T, Maeda N, Okita K, Iwahashi H, Funahashi T, Imagawa A, Shimomura I

GLP-1 receptor agonists have transformed diabetes care, but the long-term safety of GLP-1 therapies has become an important topic as treatment continues for many years

L-carnitine levels in the seminal plasma of fertile and infertile men: correlation with sperm quality

Adverse reactions related to hypotension (hypotension, orthostatic hypotension, and decreased blood pressure) were reported in 1.3% of semaglutide-treated patients versus 0.4% of placebo-treated patients during clinical trials of the semaglutide injection for weight management

Vigorous agitation shears molecular chains and accelerates aggregation